WallStSmart

Lineage, Inc. Common Stock (LINE)vsTanger Factory Outlet Centers Inc (SKT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 777% more annual revenue ($5.36B vs $611.24M). SKT leads profitability with a 20.3% profit margin vs -2.7%. SKT earns a higher WallStSmart Score of 65/100 (B-).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

SKT

Strong Buy

65

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 5.3Quality: 2.5
Piotroski: 2/9Altman Z: 0.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

SKTUndervalued (+35.5%)

Margin of Safety

+35.5%

Fair Value

$52.44

Current Price

$40.02

$12.41 discount

UndervaluedFair: $52.44Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

SKT3 strengths · Avg: 9.0/10
Operating MarginProfitability
30.3%10/10

Strong operational efficiency at 30.3%

Profit MarginProfitability
20.3%9/10

Keeps 20 of every $100 in revenue as profit

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

SKT4 concerns · Avg: 2.8/10
P/E RatioValuation
38.2x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.142/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.342/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : SKT

The strongest argument for SKT centers on Operating Margin, Profit Margin, EPS Growth. Profitability is solid with margins at 20.3% and operating margin at 30.3%. Revenue growth of 11.7% demonstrates continued momentum.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : SKT

The primary concerns for SKT are P/E Ratio, Piotroski F-Score, PEG Ratio. Debt-to-equity of 2.92 is elevated, increasing financial risk.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while SKT is a mature play — different risk/reward profiles.

SKT is growing revenue faster at 11.7% — sustainability is the question.

SKT generates stronger free cash flow (16M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SKT scores higher overall (65/100 vs 34/100), backed by strong 20.3% margins and 11.7% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.

Visit Website →

Tanger Factory Outlet Centers Inc

REAL ESTATE · REIT - RETAIL · USA

Tanger Factory Outlet Centers, Inc. (NYSE: SKT) is a leading operator of luxury outdoor outlet shopping centers that owns or has an ownership interest in a portfolio of 38 centers.

Want to dig deeper into these stocks?